OKYO Pharma (OKYO) Competitors $2.90 -0.01 (-0.34%) Closing price 07/3/2025 03:00 PM EasternExtended Trading$2.92 +0.02 (+0.66%) As of 07/3/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OKYO vs. PRTA, AQST, ALT, HRTX, PRME, SNDL, BNTC, AURA, ATXS, and AVIRShould you be buying OKYO Pharma stock or one of its competitors? The main competitors of OKYO Pharma include Prothena (PRTA), Aquestive Therapeutics (AQST), Altimmune (ALT), Heron Therapeutics (HRTX), Prime Medicine (PRME), SNDL (SNDL), Benitec Biopharma (BNTC), Aura Biosciences (AURA), Astria Therapeutics (ATXS), and Atea Pharmaceuticals (AVIR). These companies are all part of the "pharmaceutical products" industry. OKYO Pharma vs. Its Competitors Prothena Aquestive Therapeutics Altimmune Heron Therapeutics Prime Medicine SNDL Benitec Biopharma Aura Biosciences Astria Therapeutics Atea Pharmaceuticals OKYO Pharma (NASDAQ:OKYO) and Prothena (NASDAQ:PRTA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Do analysts rate OKYO or PRTA? OKYO Pharma currently has a consensus price target of $7.00, indicating a potential upside of 141.38%. Prothena has a consensus price target of $31.50, indicating a potential upside of 386.86%. Given Prothena's higher possible upside, analysts clearly believe Prothena is more favorable than OKYO Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OKYO Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Prothena 1 Sell rating(s) 4 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is OKYO or PRTA more profitable? OKYO Pharma has a net margin of 0.00% compared to Prothena's net margin of -79.94%. OKYO Pharma's return on equity of 0.00% beat Prothena's return on equity.Company Net Margins Return on Equity Return on Assets OKYO PharmaN/A N/A N/A Prothena -79.94%-21.61%-19.32% Which has more volatility and risk, OKYO or PRTA? OKYO Pharma has a beta of -0.09, indicating that its share price is 109% less volatile than the S&P 500. Comparatively, Prothena has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Does the media prefer OKYO or PRTA? In the previous week, Prothena had 2 more articles in the media than OKYO Pharma. MarketBeat recorded 2 mentions for Prothena and 0 mentions for OKYO Pharma. OKYO Pharma's average media sentiment score of 0.00 beat Prothena's score of -0.11 indicating that OKYO Pharma is being referred to more favorably in the media. Company Overall Sentiment OKYO Pharma Neutral Prothena Neutral Do insiders and institutionals believe in OKYO or PRTA? 3.0% of OKYO Pharma shares are owned by institutional investors. Comparatively, 97.1% of Prothena shares are owned by institutional investors. 40.5% of OKYO Pharma shares are owned by insiders. Comparatively, 9.2% of Prothena shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings and valuation, OKYO or PRTA? OKYO Pharma has higher earnings, but lower revenue than Prothena. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOKYO PharmaN/AN/A-$16.83MN/AN/AProthena$135.16M2.58-$122.31M-$2.08-3.11 SummaryOKYO Pharma beats Prothena on 7 of the 13 factors compared between the two stocks. Get OKYO Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OKYO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OKYO vs. The Competition Export to ExcelMetricOKYO PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$94.06M$2.91B$5.55B$9.04BDividend YieldN/A2.44%5.22%4.00%P/E RatioN/A21.5627.6420.24Price / SalesN/A275.02417.15117.30Price / CashN/A42.7336.8958.10Price / Book-14.507.518.035.67Net Income-$16.83M-$55.14M$3.18B$249.21M7 Day Performance18.37%4.61%2.93%3.28%1 Month Performance52.63%0.90%1.72%3.95%1 Year Performance141.67%5.40%34.39%20.98% OKYO Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OKYOOKYO Pharma1.8743 of 5 stars$2.90-0.3%$7.00+141.4%+141.7%$94.06MN/A0.007PRTAProthena3.0703 of 5 stars$6.31+3.9%$31.50+399.4%-68.1%$340.48M$135.16M-3.04130AQSTAquestive Therapeutics1.3841 of 5 stars$3.40+2.7%$10.14+198.4%+50.0%$338.22M$57.56M-5.77160News CoverageALTAltimmune2.2318 of 5 stars$4.09+5.7%$19.00+364.3%-28.1%$334.58M$20K-3.2750High Trading VolumeHRTXHeron Therapeutics4.0455 of 5 stars$2.16+4.1%$5.00+132.0%-24.6%$328.77M$144.29M-35.92300News CoveragePositive NewsPRMEPrime Medicine3.7502 of 5 stars$2.49+0.7%$10.08+305.3%-39.7%$327.58M$3.85M-1.22234Gap UpSNDLSNDL3.54 of 5 stars$1.23+1.2%$3.63+195.9%-34.3%$321.91M$671.81M-4.222,516News CoveragePositive NewsBNTCBenitec Biopharma2.0159 of 5 stars$12.07+3.2%$23.83+97.5%+41.4%$317.49M$80K-8.0120AURAAura Biosciences1.8899 of 5 stars$6.32+0.9%$22.00+248.4%-6.0%$317.46MN/A-3.3250Positive NewsATXSAstria Therapeutics1.9546 of 5 stars$5.59+4.2%$30.00+437.2%-36.0%$315.73MN/A-2.9930News CoverageAVIRAtea Pharmaceuticals2.3686 of 5 stars$3.59-0.3%$6.00+67.1%+12.9%$307.66MN/A-2.1870 Related Companies and Tools Related Companies PRTA Alternatives AQST Alternatives ALT Alternatives HRTX Alternatives PRME Alternatives SNDL Alternatives BNTC Alternatives AURA Alternatives ATXS Alternatives AVIR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OKYO) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OKYO Pharma Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share OKYO Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OKYO Stock Alerts